Kimberly Jewett Discusses Pathology as Part of the Treatment Process

Article

Kimberly Jewett discusses how retrieving her pathology report delayed the treatment process. Jewett says pathologists should come out from behind the microscope and engage with patients.

Kimberly Jewett, a two-time breast cancer survivor, president and CEO, Kimberly Jewett Consulting, Inc., discusses how retrieving her pathology report delayed the treatment process. Jewett says pathologists should come out from behind the microscope and engage with patients.

Recent Videos
Anne M. Reb, PhD, NP, discussing a nurse-led intervention for fear of cancer recurrence.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.